Infliximab (Inflectra®)

Assessment Status Rapid Review Complete
Drug Infliximab
Brand Inflectra®
Indication For the treatment of Rheumatoid Arthritis, Adult Crohn’s disease, Paediatric Crohn’s disease, Ulcerative Colitis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis.
Assessment Process
Rapid review commissioned 10/09/2013
Rapid review completed 20/09/2013
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended